Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,443 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

SGI-110 in Combination With Carboplatin in Ovarian Cancer

NCT01696032

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Norris Comprehensive Cancer Center- University of Southern California Los Angeles, California, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Georgia Health Sciences University Augusta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View all 24 locations
View Trial Details
Completed

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

NCT04570839

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Oncology Center. Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
View Trial Details
Completed

Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer

NCT03759600

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • The Jikei University Kashiwa Hospital Kashiwa, Chiba, Japan
View all 33 locations
View Trial Details
Completed

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

NCT03759587

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki, Aomori, Japan
  • Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Ehime University Hospital Tōon, Ehime, Japan
View all 27 locations
View Trial Details

Related conditions